Bronchitis Treatment Market

Bronchitis Treatment Market (Type - Chronic Bronchitis, Acute Bronchitis; Drug Class - Antibiotics, Anti-inflammatory Drugs, Bronchodilator, Mucolytics; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

  • Rep Id : TMRGL62775
  • Published On : Mar 2019
  • No. of Pages : 176
  • Category : Pharmaceutical

1. Preface 
     1.1. Report Scope and Market Segmentation 
     1.2. Research Highlights

2. Assumptions and Research Methodology 
     2.1. Assumptions and Acronyms Used
     2.2. Research Methodology

3. Executive Summary
     3.1. Global Bronchitis Treatment Market: Market Snapshot

4. Market Overview
     4.1. Global Bronchitis Treatment Market: Type Overview 
     4.2. Global Bronchitis Treatment Market: Key Industry Developments
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities
     4.4. Global Bronchitis Treatment Market Revenue Projections, 2016–2026
     4.5. Porter’s Five Forces Analysis
     4.6. Global Bronchitis Treatment Market Outlook

5. Market Outlook
     5.1. Pipeline Analysis
     5.2. Key Market Trends
     5.3. Disease Epidemiology

6. Global Bronchitis Treatment Market Analysis, by Type
     6.1. Key Findings
     6.2. Introduction
     6.3. Global Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Type
     6.4. Global Bronchitis Treatment Market Value Forecast, by Type
            6.4.1. Acute Bronchitis
            6.4.2. Chronic Bronchitis
     6.5. Global Bronchitis Treatment Market Analysis, by Type

7. Global Bronchitis Treatment Market Analysis and Forecast, by Drug Class
     7.1. Key Findings
     7.2. Introduction
     7.3. Global Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Drug Class
     7.4. Global Bronchitis Treatment Market Value Forecast, by Drug Class
            7.4.1. Antibiotics
            7.4.2. Anti-inflammatory Drugs
            7.4.3. Bronchodilators
            7.4.4. Mucolytics
     7.5. Global Bronchitis Treatment Market Analysis, by Drug Class

8. Global Bronchitis Treatment Market Analysis, by Distribution Channel
     8.1. Key Findings
     8.2. Introduction
     8.3. Global Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel
     8.4. Global Bronchitis Treatment Market Value Forecast, by Distribution Channel
            8.4.1. Hospital Pharmacies
            8.4.2. Retail Pharmacies
            8.4.3. Online Pharmacies
     8.5. Global Bronchitis Treatment Market Analysis, by Distribution Channel

9. Global Bronchitis Treatment Market Analysis, by Region
     9.1. Global Bronchitis Treatment Market Scenario, by Country
     9.2. Global Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Region
     9.3. Global Bronchitis Treatment Market Value Forecast, by Region
            9.3.1. North America
            9.3.2. Europe
            9.3.3. Asia Pacific 
            9.3.4. Latin America
            9.3.5. Middle East & Africa

10. North America Bronchitis Treatment Market Analysis
     10.1. Key Findings
     10.2. North America Bronchitis Treatment Market Overview
     10.3. North America Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Country
     10.4. North America Bronchitis Treatment Market Forecast, by Country
            10.4.1. U.S.
            10.4.2. Canada
     10.5. North America Bronchitis Treatment Market Value Share Analysis, by Type
     10.6. North America Bronchitis Treatment Market Forecast, by Type
            10.6.1. Acute Bronchitis
            10.6.2. Chronic Bronchitis
     10.7. North America Bronchitis Treatment Market Value Share Analysis, by Drug Class
     10.8. North America Bronchitis Treatment Market Forecast, by Drug Class
            10.8.1. Antibiotics
            10.8.2. Anti-inflammatory Drugs
            10.8.3. Bronchodilators
            10.8.4. Mucolytics
     10.9. North America Bronchitis Treatment Market Value Share Analysis, by Distribution Channel
     10.10. North America Bronchitis Treatment Market Forecast, by Distribution Channel
            10.10.1. Hospital Pharmacies
            10.10.2. Retail Pharmacies
            10.10.3. Online Pharmacies
     10.11. North America Bronchitis Treatment Market Attractiveness Analysis

11. Europe Bronchitis Treatment Market Analysis
     11.1. Key Findings
     11.2. Europe Bronchitis Treatment Market Overview
     11.3. Europe Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
     11.4. Europe Bronchitis Treatment Market Forecast, by Country/Sub-region
            11.4.1. Germany
            11.4.2. U.K.
            11.4.3. France
            11.4.4. Italy
            11.4.5. Spain
            11.4.6. Rest of Europe
     11.5. Europe Bronchitis Treatment Market Value Share Analysis, by Type
     11.6. Europe Bronchitis Treatment Market Forecast, by Type
            11.6.1. Acute Bronchitis
            11.6.2. Chronic Bronchitis
     11.7. Europe Bronchitis Treatment Market Value Share Analysis, by Drug Class
     11.8. Europe Bronchitis Treatment Market Forecast, by Drug Class
            11.8.1. Antibiotics
            11.8.2. Anti-inflammatory Drugs
            11.8.3. Bronchodilators
            11.8.4. Mucolytics
     11.9. Europe Bronchitis Treatment Market Value Share Analysis, by Distribution Channel
     11.10. Europe Bronchitis Treatment Market Forecast, by Distribution Channel
            11.10.1. Hospital Pharmacies
            11.10.2. Retail Pharmacies
            11.10.3. Online Pharmacies
     11.11. Europe Bronchitis Treatment Market Attractiveness Analysis

12. Asia Pacific Bronchitis Treatment Market Analysis
     12.1. Key Findings
     12.2. Asia Pacific Bronchitis Treatment Market Overview
     12.3. Asia Pacific Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
     12.4. Asia Pacific Bronchitis Treatment Market Forecast, by Country/Sub-region
            12.4.1. China
            12.4.2. India
            12.4.3. Japan
            12.4.4. Australia & New Zealand
            12.4.5. Rest of Asia Pacific
     12.5. Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Type
     12.6. Asia Pacific Bronchitis Treatment Market Forecast, by Type
            12.6.1. Acute Bronchitis
            12.6.2. Chronic Bronchitis
     12.7. Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Drug Class
     12.8. Asia Pacific Bronchitis Treatment Market Forecast, by Drug Class
            12.8.1. Antibiotics
            12.8.2. Anti-inflammatory Drugs
            12.8.3. Bronchodilators
            12.8.4. Mucolytics
     12.9. Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Distribution Channel
     12.10. Asia Pacific Bronchitis Treatment Market Forecast, by Distribution Channel
            12.10.1. Hospital Pharmacies
            12.10.2. Retail Pharmacies
            12.10.3. Online Pharmacies
     12.11. Asia Pacific Bronchitis Treatment Market Attractiveness Analysis

13. Latin America Bronchitis Treatment Market Analysis
     13.1. Key Findings
     13.2. Latin America Bronchitis Treatment Market Overview
     13.3. Latin America Bronchitis Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
     13.4. Latin America Bronchitis Treatment Market Forecast, by Country/Sub-region
            13.4.1. Brazil
            13.4.2. Mexico
            13.4.3. Rest of Latin America
     13.5. Latin America Bronchitis Treatment Market Value Share Analysis, by Type
     13.6. Latin America Bronchitis Treatment Market Forecast, by Type
            13.6.1. Acute Bronchitis
            13.6.2. Chronic Bronchitis
     13.7. Latin America Bronchitis Treatment Market Value Share Analysis, by Drug Class
     13.8. Latin America Bronchitis Treatment Market Forecast, by Drug Class
            13.8.1. Antibiotics
            13.8.2. Anti-inflammatory Drugs
            13.8.3. Bronchodilators
            13.8.4. Mucolytics
     13.9. Latin America Bronchitis Treatment Market Value Share Analysis, by Distribution Channel
     13.10. Latin America Bronchitis Treatment Market Forecast, by Distribution Channel
            13.10.1. Hospital Pharmacies
            13.10.2. Retail Pharmacies
            13.10.3. Online Pharmacies
     13.11. Latin America Bronchitis Treatment Market Attractiveness Analysis

14. Middle East & Africa Bronchitis Treatment Market Analysis
     14.1. Key Findings
     14.2. Middle East & Africa Bronchitis Treatment Market Overview
     14.3. Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Country/Sub-region
     14.4. Middle East & Africa Bronchitis Treatment Market Forecast, by Country/Sub-region
            14.4.1. GCC Countries
            14.4.2. South Africa
            14.4.3. Rest of Middle East and Africa
     14.5. Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Type
     14.6. Middle East & Africa Bronchitis Treatment Market Forecast, by Type
            14.6.1. Acute Bronchitis
            14.6.2. Chronic Bronchitis
     14.7. Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Drug Class
     14.8. Middle East & Africa Bronchitis Treatment Market Forecast, by Drug Class
            14.8.1. Antibiotics
            14.8.2. Anti-inflammatory Drugs
            14.8.3. Bronchodilators
            14.8.4. Mucolytics
     14.9. Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Distribution Channel
     14.10. Middle East & Africa Bronchitis Treatment Market Forecast, by Distribution Channel
            14.10.1. Hospital Pharmacies
            14.10.2. Retail Pharmacies
            14.10.3. Online Pharmacies
     14.11. Middle East & Africa Bronchitis Treatment Market Attractiveness Analysis

15. Competition Landscape
     15.1. Bronchitis Treatment Market Share Analysis, by Company, 2017
     15.2. Competition Matrix
     15.3. Company Profiles
            15.3.1. AstraZeneca
                      15.3.1.1. Company Details
                      15.3.1.2. Business Overview
                      15.3.1.3. Financial Overview
                      15.3.1.4. Strategic Overview
                      15.3.1.5. SWOT Analysis
            15.3.2. Boehringer Ingelheim International GmbH
                      15.3.2.1. Company Details
                      15.3.2.2. Business Overview
                      15.3.2.3. Financial Overview
                      15.3.2.4. Strategic Overview
                      15.3.2.5. SWOT Analysis
            15.3.3. GlaxoSmithKline plc
                      15.3.3.1. Company Details
                      15.3.3.2. Business Overview
                      15.3.3.3. Financial Overview
                      15.3.3.4. Strategic Overview
                      15.3.3.5. SWOT Analysis
            15.3.4. Novartis AG
                      15.3.4.1. Company Details
                      15.3.4.2. Business Overview
                      15.3.4.3. Financial Overview
                      15.3.4.4. Strategic Overview
                      15.3.4.5. SWOT Analysis
            15.3.5. Melinta Therapeutics
                      15.3.5.1. Company Details
                      15.3.5.2. Business Overview
                      15.3.5.3. Financial Overview
                      15.3.5.4. Strategic Overview
                      15.3.5.5. SWOT Analysis
            15.3.6. Dr Reddy's Laboratories Ltd
                      15.3.6.1. Company Details
                      15.3.6.2. Business Overview
                      15.3.6.3. Financial Overview
                      15.3.6.4. Strategic Overview
                      15.3.6.5. SWOT Analysis
            15.3.7. Sanofi S.A.
                      15.3.7.1. Company Details
                      15.3.7.2. Business Overview
                      15.3.7.3. Financial Overview
                      15.3.7.4. Strategic Overview
                      15.3.7.5. SWOT Analysis

List of Tables

Table 01: Pipeline Analysis
Table 02: Global Bronchitis Treatment Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 03: Global Bronchitis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 04: Global Bronchitis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 05: Global Bronchitis Treatment Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 07: North America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 08: North America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 09: North America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 10: Europe Bronchitis Treatment Market Value (US$ Mn) Forecast, by Country/Region 2016–2026
Table 11: Europe Bronchitis Treatment Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 12: Europe Bronchitis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 13: Europe Bronchitis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 14: Asia Pacific Bronchitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region 2016–2026
Table 15: Asia Pacific Bronchitis Treatment Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 16: Asia Pacific Bronchitis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 17: Asia Pacific Bronchitis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 18: Latin America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 19: Latin America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 20: Latin America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 21: Latin America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 22: Middle East & Africa Bronchitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region,
Table 23: Middle East & Africa Bronchitis Treatment Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 24: Middle East & Africa Bronchitis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 25: Middle East & Africa Bronchitis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026

List of Figures

Figure 01: Global Bronchitis Treatment Market Value (US$ Mn) and Distribution, by Region, 2018 and 2026
Figure 02: Global Bronchitis Treatment Market Revenue Projection (US$ Mn), 2016–2026
Figure 03: Global Bronchitis Treatment Market Value Share, by Type, 2017
Figure 04: Global Bronchitis Treatment Market Value Share, by Drug Class, 2017
Figure 05: Global Bronchitis Treatment Market Value Share, by Region, 2017
Figure 06: Global Bronchitis Treatment Market Value Share, by Distribution Channel, 2017
Figure 07: Global Bronchitis Treatment Market Value Share Analysis by Type, 2017 and 2026
Figure 08: Global Bronchitis Treatment Market Attractiveness, by Type, 2018–2026
Figure 09: Global Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Chronic Bronchitis, 2016–2026
Figure 10: Global Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Acute Bronchitis, 2016–2026
Figure 11: Global Bronchitis Treatment Market Value Share Analysis by Drug Class, 2017 and 2026
Figure 12: Global Bronchitis Treatment Market Attractiveness, by Drug Class, 2018–2026
Figure 13: Global Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Antibiotics, 2016–2026
Figure 14: Global Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Anti-Inflammatory Drugs, 2016–2026
Figure 15: Global Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Bronchodilators, 2016–2026
Figure 16: Global Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Mucolytics, 2016–2026
Figure 17: Global Bronchitis Treatment Market Value Share, by Distribution Channel, 2017 and 2026
Figure 18: Global Bronchitis Treatment Market Attractiveness, by Distribution Channel, 2018–2026
Figure 19: Global Bronchitis Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2016–2026
Figure 20: Global Bronchitis Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2016–2026
Figure 21: Global Bronchitis Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Pharmacies, 2016-2026
Figure 22: Global Bronchitis Treatment Market Value Share, by Region, 2016 and 2025 
Figure 23: Global Bronchitis Treatment Market Attractiveness, by Region, 2018–2026
Figure 24: North America Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
Figure 25: North America Bronchitis Treatment Market Value Share Analysis, by Country, 2017 and 2026
Figure 26: North America Bronchitis Treatment Market Attractiveness Analysis, by Country, 2018-2026
Figure 27: North America Bronchitis Treatment Market Value Share Analysis, by Type, 2017 and 2026
Figure 28: North America Bronchitis Treatment Market Value Share Analysis, by Drug Class, 2017 and 2026
Figure 29: North America Bronchitis Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 30: North America Bronchitis Treatment Market Attractiveness Analysis, by Type, 2018–2026
Figure 31: North America Bronchitis Treatment Market Attractiveness Analysis, by Drug Class, 2018–2026
Figure 32: North America Bronchitis Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 33: Europe Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
Figure 34: Europe Bronchitis Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 35: Europe Bronchitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
Figure 36: Europe Bronchitis Treatment Market Value Share Analysis, by Type, 2017 and 2026
Figure 37: Europe Bronchitis Treatment Market Value Share Analysis, by Drug Class, 2017 and 2026
Figure 38: Europe Bronchitis Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 39: Europe Bronchitis Treatment Market Attractiveness Analysis, by Type, 2018–2026
Figure 40: Europe Bronchitis Treatment Market Attractiveness Analysis, by Drug Class, 2018–2026
Figure 41: Europe Bronchitis Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 42: Asia Pacific Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 43: Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 44: Asia Pacific Bronchitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
Figure 45: Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Type, 2017 and 2026
Figure 46: Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Drug Class, 2017 and 2026
Figure 47: Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 48: Asia Pacific Bronchitis Treatment Market Attractiveness Analysis, by Type, 2018–2026
Figure 49: Asia Pacific Bronchitis Treatment Market Attractiveness Analysis, by Drug Class, 2018–2026
Figure 50: Asia Pacific Bronchitis Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 51: Latin America Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 52: Latin America Bronchitis Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 53: Latin America Bronchitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
Figure 54: Latin America Bronchitis Treatment Market Value Share Analysis, by Type, 2017 and 2026
Figure 55: Latin America Bronchitis Treatment Market Value Share Analysis, by Drug Class, 2017 and 2026
Figure 56: Latin America Bronchitis Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 57: Latin America Bronchitis Treatment Market Attractiveness Analysis, by Type, 2018–2026
Figure 58: Latin America Bronchitis Treatment Market Attractiveness Analysis, by Drug Class, 2018–2026
Figure 59: Latin America Bronchitis Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 60: Middle East & Africa Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 61: Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 62: Middle East & Africa Bronchitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 63: Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Type, 2017 and 2026
Figure 64: Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Drug Class, 2017 and 2026
Figure 65: Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 66: Middle East & Africa Bronchitis Treatment Market Attractiveness Analysis, by Type, 2018–2026
Figure 67: Middle East & Africa Bronchitis Treatment Market Attractiveness Analysis, by Drug Class, 2018–2026
Figure 68: Middle East & Africa Bronchitis Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 69: Global Bronchitis Treatment Market Share, by Company, 2017
Figure 70: AstraZeneca Breakdown of Net Sales (%), by Region, 2017
Figure 71: AstraZeneca R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 72: AstraZeneca Breakdown of Net Sales (%), by Product Segment, 2017
Figure 73: Boehringer Ingelheim International GmbH, Human Pharmaceuticals Business Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 74: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Region, 2017
Figure 75: Boehringer Ingelheim International GmbH R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 76: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Business Segment, 2017
Figure 77: GlaxoSmithKline plc Respiratory Business Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 78: GlaxoSmithKline plc Breakdown of Net Sales (%), by Region, 2017
Figure 80: GlaxoSmithKline plc Breakdown of Net Sales (%), by Business Segment, 2017
Figure 81: Novartis AG COPD Portfolio Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 82: Novartis AG Breakdown of Net Sales (%), by Country, 2017
Figure 83: Novartis AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 84: Novartis AG Breakdown of Net Sales (%), by Business Segment, 2017
Figure 85: Melinta Therapeutics Respiratory Medicine Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 86: Melinta Therapeutics Breakdown of Net Sales (%), by Region, 2017
Figure 87: Melinta Therapeutics R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 88: Melinta Therapeutics Breakdown of Net Sales (%), by Business Segment, 2017
Figure 89: Dr Reddy's Laboratories Ltd., Ltd Pharmaceuticals Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 90: Dr Reddy's Laboratories Ltd., Breakdown of Net Sales (%), by Region, 2017
Figure 91: Dr Reddy's Laboratories Ltd., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 92: Dr Reddy's Laboratories Ltd., Breakdown of Net Sales (%), by Product Segment, 2017
Figure 93: Sanofi S.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 94: Sanofi S.A. Breakdown of Net Sales (%), by Region, 2017
Figure 95: Sanofi S.A. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 96: Sanofi S.A. Breakdown of Net Sales (%), by Therapeutics Area, 2017

.